Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content
HomeSwitching guideWegovyZepbound

Medication switch

Switching from Wegovy to Zepbound

semaglutide → tirzepatide — re-titration required

Semaglutide → tirzepatide for weight loss — strongest head-to-head data favors tirzepatide.

Medically reviewed by Dr. Jane Novak, MD, MPH on May 15, 2026

1 min read

Cross-ingredient switch — re-titration required

Wegovy uses semaglutide; Zepbound uses tirzepatide. You restart from the starter dose and re-titrate over 12–20 weeks to reduce GI side effects.

Why patients make this switch

  • 1Plateau on max Wegovy 2.4 mg dose with goal weight not reached.
  • 2SURMOUNT-5 head-to-head data shows tirzepatide achieves greater mean weight loss.
  • 3Wegovy starter-dose shortage during 2024-2026 made initiation difficult.
  • 4LillyDirect self-pay vials offer cheaper option than Wegovy pens.

Dose transition

These medications use different active ingredients (semaglutide vs. tirzepatide). Re-titration from the starter dose is required to reduce GI side effects.

Timeline & titration

Start Zepbound 2.5 mg for 4 weeks then escalate to 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg as tolerated. Most patients stabilize at 10 mg or 15 mg for weight management. Full titration from Wegovy 2.4 mg to Zepbound 15 mg is 20 weeks.

Side-effect transition

Expect nausea and constipation to return during re-titration. The SURMOUNT trials show side-effect rates similar between products at maintenance — the difference is the re-titration period.

Insurance & cost

Zepbound PA same as Wegovy. Some insurers may consider it a "switch within class" and require new step-through documentation. LillyDirect self-pay vials at $349-$549/month are an option Wegovy does not offer.

When this switch is NOT recommended

  • You are losing weight steadily on Wegovy and tolerating it well.
  • You cannot afford a 12-20 week titration plateau before reaching the new maintenance dose.

Switching to Zepbound? Book a telehealth visit.

Our ranked telehealth providers handle switching prescriptions, prior authorizations, and pharmacy coordination — typically 1–3 business days end to end.

See top providers

Editorial ranking is independent of commission rates.

Frequently asked questions

Is Zepbound better than Wegovy for weight loss?

In the SURMOUNT-5 head-to-head trial (Aronne et al., NEJM 2025), tirzepatide 15 mg achieved 20.2% mean weight loss vs. semaglutide 2.4 mg at 14.3% over 72 weeks. Individual response varies; the trial does not predict outcomes in every patient.

Other switching guides

All 12 switching guides

Keep exploring

Resources for patients moving from Wegovy to Zepbound.

People also ask

Common questions readers ask

Can you drink alcohol on Wegovy?
No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol — likely a secondary effect of GLP-1 on the brain reward system.
Full evidence-graded answer
Does GLP-1 affect oral birth control?
Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect.
Full evidence-graded answer
Can I take GLP-1 while pregnant?
No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life.
Full evidence-graded answer
Is it safe to take GLP-1 long-term?
Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity.
Full evidence-graded answer
Do I need to exercise on Wegovy?
Yes — resistance training specifically. Without it, 25-40% of weight lost on GLP-1 comes from lean muscle. Cardio is a bonus; resistance is the non-negotiable.
Full evidence-graded answer